Hyperglycemia and Acute Coronary Syndrome
Authors:
- Prakash DeedwaniaPDPrakash Deedwania
- Mikhail KosiborodMKMikhail Kosiborod
- Eugene BarrettEBEugene Barrett
- Antonio CerielloACAntonio Ceriello
- William IsleyWIWilliam Isley
- Theodore MazzoneTMTheodore Mazzone
- Philip RaskinPRPhilip Raskin
- 25 March 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 117 (12) , 1610-1619
Abstract
Hyperglycemia is common and associated with markedly increased mortality rates in patients hospitalized with acute coronary syndromes (ACS). Despite the fact that several studies have documented this association, hyperglycemia remains underappreciated as a risk factor, and it is frequently untreated in ACS patients. This is in large part due to limitations of prior studies, and the remaining critical gaps in our understanding of the relationship between hyperglycemia and poor outcomes. The main objective of the present statement is to summarize the current state of knowledge regarding the association between elevated glucose and patient outcomes in ACS and to outline the most important knowledge gaps in this field. These gaps include the need to specifically define hyperglycemia, develop optimal ways of measuring and tracking glucose values during ACS hospitalization, and better understand the physiological mechanisms responsible for poor outcomes associated with hyperglycemia. The most important issue, however, is whether elevated glucose is a direct mediator of adverse outcomes in ACS patients or just a marker of greater disease severity. Given the marked increase in short- and long-term mortality associated with hyperglycemia, there is an urgent need for definitive large randomized trials to determine whether treatment strategies aimed at glucose control will improve patient outcomes and to define specific glucose treatment targets. Although firm guidelines will need to await completion of these clinical trials, the present statement also provides consensus recommendations for hyperglycemia management in patients with ACS on the basis of the available data.Keywords
This publication has 75 references indexed in Scilit:
- Intensive Insulin Therapy in the Medical ICUNew England Journal of Medicine, 2006
- Relation of Chronic and Acute Glycemic Control on Mortality in Acute Myocardial Infarction With Diabetes MellitusThe American Journal of Cardiology, 2005
- Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarctionAmerican Heart Journal, 2003
- Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarctionJACC, 2003
- Molecular Mechanisms of Tumor Necrosis Factor α Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent PathwaysJournal of Biological Chemistry, 2000
- Insulin Administered at Reoxygenation Exerts a Cardioprotective Effect in Myocytes by a Possible Anti-Apoptotic MechanismJournal of Molecular and Cellular Cardiology, 2000
- Kinetics of tumor necrosis factor α in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor α in acute myocardial infarctionAmerican Heart Journal, 1999
- Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.Journal of Clinical Investigation, 1998
- Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitusThe American Journal of Cardiology, 1989
- RELATION BETWEEN PLASMA FREE FATTY ACIDS AND ARRHYTHMIAS WITHIN THE FIRST TWELVE HOURS OF ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1983